Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medical Devices
Safety Information
Safety communications
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
COVID-19 Updates
Our role
Safety Information
Reporting safety issues
Monitoring device safety
Safety communications
About HPRA Safety Notices
Manufacturer's Field Safety Notices
User Engagement
Consumer advice
Regulatory Information
Registration
Medical Devices News & Events
Special Topics
Contact Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
FreeStyle Mini® and FreeStyle® Blood Glucose Monitoring Systems
Notice type:
Advisory
Date:
21/02/2014
Product name or type:
FreeStyle Mini® and FreeStyle® Blood Glucose Monitoring Systems
Reference:
SN2014(06)
Manufacturer Or Supplier:
Abbott Diabetes Care
Target Audience:
All Hospital staff
All Nursing Home staff
Risk Managers
Nursing Managers
Hospital Pharmacists
Diabetic Clinics/ outpatients
Diabetic nurse specialists
Diabetic departments
Endocrinology units
Endocrinology Consultants
Paediatric wards
Laboratory Managers
Chief Medical Scientists
Purchasing / Procurement / Material Managers
Pharmacists supplying these devices
General Practitioners
Healthcare professionals who use these devices
Healthcare professionals managing patients who use these devices
Carers
General public
Problem Or Issue:
The Irish Medicines Board (IMB) has been notified that FreeStyle Mini® Blood Glucose Meters and FreeStyle® Blood Glucose Meters may give erroneously low blood glucose results and may produce out of range control solution results when using FreeStyle Lite® and FreeStyle® Blood Glucose Test Strips.
Background Information Or Related Documents:
Abbott Diabetes Care (UK) has advised that the affected blood glucose meters (FreeStyle Mini® and FreeStyle® Blood Glucose Meters) have been supplied to the Irish market.
The current issue affects all FreeStyle Mini® and FreeStyle® Blood Glucose Meters when used with any FreeStyle test strip lots (refer to attached FSN). Affected meters were placed on the Irish market between January 2004 and September 2007. Abbott Diabetes Care (UK) has confirmed that the above meters are the only affected meters supplied to the Irish market and no adverse incidents related to this issue have been reported for the Irish market.
A previous Safety Notice (SN2013(14)) issued by the IMB on 4th December 2013 advised that certain lots of FreeStyle Lite® Blood Glucose Test Strips may give erroneously low blood glucose results when using FreeStyle Mini® and FreeStyle® Blood Glucose Meters – see attached FSN.
FreeStyle Mini® and FreeStyle® Blood Glucose Monitoring Systems Document
Actions To Be Taken:
Advice for End Users / Patients:
1. Follow the manufacturer’s instructions outlined in the attached FSN and contact Abbott Diabetes Care Customer Service on 1800 776633 for a replacement meter.
2. Ensure that you can continue to monitor your blood glucose appropriately. This should be done in consultation with your healthcare professional.
3. Pay special attention to signs and symptoms of high blood sugar (hyperglycemia). Symptoms may include excessive thirst, excessive urination, blurred vision, weakness, nausea, vomiting and abdominal pain. If you are
experiencing any of these symptoms or are not feeling well, contact your healthcare professional immediately.
Advice for Healthcare Professionals / Pharmacists / Distributors:
1. Follow the manufacturer’s instructions outlined in the attached FSN and contact Abbott Diabetes Care Customer Service on 1800 776633 for replacement meters.
2. Ensure that end users who dispose of affected blood glucose meters can continue to appropriately monitor their blood glucose.
3. Ensure that the appropriate personnel are made aware of this notice and the attached FSN. Please also pass this notice and the attached FSN on to any end user or organisation where the potentially affected blood glucose meters have been transferred.
Further Information:
Enquiries to the manufacturer should be addressed to:
Barbara Scott
Abbott Diabetes Care
4051 Kingswood Drive
Citywest Business Campus
Dublin 24
Telephone: 1800 776633
E-mail:
ADChelpuk@abbott.com
All adverse incidents relating to a medical device should be reported to the:
Health Products Regulatory Authority
Kevin O’Malley House
Earlsfort Centre
Earlsfort Terrace
Dublin 2
Telephone: +353-1-6764971
Fax: +353-1-6344033
E-mail:
devicesafety@hpra.ie
Website:
www.hpra.ie
Please click here to view a copy of the 1st FSN
Please click here to view a copy of the 2nd FSN
Please click here to view a PDF version of this Safety Notice
« Back
Date Printed: 19/09/2024